We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+16.2%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$126M
AUM Growth
+$27.3M
(+27%)
Cap. Flow
+$10M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
54.03%
Holding
70
New
10
Increased
16
Reduced
10
Closed
7
Top Buys
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$3.68M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$3.29M |
| 3 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$2.09M |
| 4 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
+$1.56M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$1.51M |
Top Sells
| 1 |
XNPT
XENOPORT, INC.
XNPT
|
+$1.04M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$1.04M |
| 3 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
+$1.01M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$683K |
| 5 |
Vericel Corp
VCEL
|
+$681K |
Sector Composition
| 1 | Healthcare | 60.28% |
| 2 | Financials | 0.92% |
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML